Allergan plc (AGN) said that the U.S. Food and Drug Administration has accepted the New Drug Application or NDA for ulipristal acetate, an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids.
from RTT - Biotech http://ift.tt/2i1yzbL
via IFTTT
No comments:
Post a Comment